Hep B during Pregnancy
Hepatic Encephalopathy and lactose
Which of the following marker would indicate thiopurine resistance?
Use of azathoprine
A low 6-TGN and a high 6-MMP would indicate that the patient has Thiopurine resistance and therefore the management would be to add allopurinol and reduce thiopurine dose.
Endoscopy screening in Barrett’s
Recurrent C.Diff infection management
The infusion of donor feces was significantly more effective for the treatment of recurrent C. difficile infection than the use of vancomycin.
Colorectal Ca screening in 1st degree relative +ve
Inactive hepatitis B surface antigen (HBsAg) carrier state.
– HBsAg and HBcAb are positive. – normal liver enzymes (AST and ALT) – HBeAg and HBV DNA are negative – HBeAb is positive **** – asymptomatic
Chronic hepatitis B, which is divided into HBeAg positive and HBeAg negative chronic hepatitis B
HBeAg positive: – HBsAg positive. – HBV DNA positive – liver enzymes are persistently or intermittently elevated HBeAg negative(Precore mutant): – HBsAg positive. – HBV DNA positive – liver enzymes are persistently or intermittently elevated
Resolved chronic hepatitis B (Past infection
– HBsAg negative
– HBsAb positive
– normalization of ALT and AST
– very low levels of HBV DNA(less than 10,000 copies/ml)
H.Pylori Irradication
1) PPI + clarithromycin + amoxycillin for 10-14 days
If Failed
2) PPI + Bismuth + Tetracycline + Metronidazole for 10-14 days.
Then therapy: PPI + Amoxycillin for 5 days,
then followed by PPI + Clarithromycin + Tinidazole for 5 days.
Susceptibility driven therapy.
Salvage therapy: Levofloxacin (either triple or sequential) or Rifabutin triple therapy.
Multitarget Stool DNA testing for colorectal cancer
Leptin function
1) Inhibits food intake
- reduces the expression of neurotransmitters that increase food intake ie: Neuropeptide Y and agouti-related peptide.
2) Increases energy expenditure.
Indications for Liver transplant - HCC
Hepatocellular carcinoma
– single lesion between 2 to 5 cm or
– no more than three lesions, the largest of which is less than 3 cm, and no radiographic evidence of extrahepatic disease.
– Liver transplantation should be viewed as the treatment of choice for selected patients with hepatocellular carcinoma who are not candidates for surgical resection and in whom malignancy is confined to the liver
Cirrhosis:
– referred for transplantation when they develop evidence of hepatic dysfunction (Child Pugh Score > 7 and MELD > 10) or when they experience their first major complication (ascites, variceal bleeding, or hepatic encephalopathy)
Indications for Liver transplant Hepatorenal syndrome:
– Patients with type I hepatorenal syndrome should have an expedited referral for liver transplantation